CDER's Drug-Drug Interaction Database Will Be Functional By 2000
Executive Summary
CDER's drug-drug interaction scientific database will be functional two years ahead of schedule, FDA's fiscal 1999 revision to the Prescription Drug User Fee Act Information Management Plan indicates.
You may also be interested in...
User Fee Revision Reduces Expected CDER Staffing Increases By 139 FTEs
A revision of FDA's estimated revenues from user fees will reduce the expected additions in staff to the Center for Drug Evaluation & Research to 40% of previous estimates.
User Fee Revision Reduces Expected CDER Staffing Increases By 139 FTEs
A revision of FDA's estimated revenues from user fees will reduce the expected additions in staff to the Center for Drug Evaluation & Research to 40% of previous estimates.
Electronic Full NDA Filings Projected By Mid-1999; 14% User Fees Go To IT
FDA's electronic submissions program will be equipped to accept full NDA submissions by September 1999, FDA reported in its Prescription Drug User Fee Act Information Management Five-Year Plan, released with the PDUFA II Five-Year Plan on July 10.